Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Julien Lambert Headshot

Julien

Lambert

,

MD, PhD

University Hospital of Antwerp
Antwerp
,
Belgium
Dr. Julien Lambert completed his residency in Dermatology in 1987 at the University of Antwerp, followed by an additional year of training with a special focus on photodermatology at the Hôpital Saint-Louis in Paris. He received his master’s in economic sciences at the University of Antwerp in 1989, where his thesis was on the economic cost of HIV in Belgium. In 1994, he obtained his PhD in provocation tests of polymorphic light eruption. He was appointed Chairman of the Department of Dermatology at the Antwerp University Hospital in 1997. His main interests are general dermatology (acne, atopic dermatitis, psoriasis), photodermatology, pharmaco-economics, dermato-epidemiology, and topical dermatology.

Dr. Lambert was president of the Royal Belgian Society of Dermatology and Venereology from 2002 to 2007 and was a member of the Board and Finance Committee of the European Academy of Dermatology and Venereology (EADV) from 2007 to 2013. He is a professor emeritus and still works at the University Hospital of Antwerp. He is treasurer of the Royal Belgian Society of Dermatology, Charmain of the Finance Committee of the EADV, and Past-President of the Fondation Rene-Touraine e-dermatology portal committee.
Last Updated:
04/15/2025

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026